Explore Companies

"No child should die in the dawn of life." -Danny Thomas, Founder, St. Jude Children's Research Hospital Over 70 years ago, Danny Thomas was a young entertainer with a baby on the way. Work wasn't easy to come by, and his despair grew. He turned to St. Jude Thaddeus, the patron saint of hopeless causes, and vowed, "Show me my way in life, and I will build you a shrine." His shrine would become St. Jude Children's Research Hospital. Today, St. Jude Children’s Research Hospital is a global leader in the research and treatment of pediatric cancer and other life-threatening diseases of childhood. St. Jude is recognized as one of the world’s premier pediatric research and treatment institutions with a focus on acute lymphoblastic leukemia, brain tumors and infectious diseases. Research and treatments developed at St. Jude are shared to help improve the survival rate for children with cancer and other life-threatening diseases worldwide. Headquartered in Memphis, Tennessee, St. Jude Children's Research Hospital is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. St. Jude has been named a top pediatric cancer hospital on U.S. News & World Report’s annual "Best Hospitals" list and named to Fortune magazine’s "100 Best Companies to Work For" list. With eight affiliate clinics across the country, St. Jude treats almost 10,000 children each year. Beyond the United States, the institution’s St. Jude Global initiative seeks to improve health care for children with life-threatening disease worldwide.

AgroStar serves millions of farmers across five Indian states via an omnichannel approach. Along the journey we have built India’s largest agronomy advisory center, a highly engaged digital farmer network with over five million users and a retail network of more than one thousand five hundred stores. These channels, powered by technology, work in tandem to enable us to solve the problems faced by farmers at scale and we are just getting started. Funded by prominent investors like Chiratae Venture Partners, Aavishkaar Ventures, Accel Partners, Schroders Capital, Evolvence Group, Hero Enterprise,Bertelsmann Investments,Rabo Frontier Ventures,IFC and CDC we are rapidly growing our agri-input platform and making strategic investments to solve other farmer problems like market linkages and access to credit. At AgroStar, we provide an open work culture for you to carve your own path and contribute with your unique insight. We believe that we are developing future entrepreneurs for the country here, so if you are passionate about solving important problems in a sector that employs more than half of our country's population, explore opportunities at https://ulinkagritech.hire.trakstar.com/.

Plivo is a communications platform that enables businesses to connect, engage and interact with their customers. Plivo simplifies the notorious complexity of telecom by offering simple and enterprise-grade building blocks. Plivo's infrastructure handles billions of voice calls and messages every year from businesses around the world It all started in 2011, when Plivo's founders, Mike and Venky, met on Github. They had been seeking a robust communication solution that worked globally. Failing to find one, they decided to build their own; hence Plivo was born. Today more than 70,000 customers use Plivo to add Voice Calling and Messaging capabilities to their web, mobile and desktop apps.

Corporate Travel Booking Solutions Deem Work Fource is a suite of cloud and corporate travel software applications that saves your travelers time booking and traveling, saves you money on air, hotel and ground - and helps you both get more done in less time, with more choice.

UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We're here because we want to transform patients’ lives by pushing the boundaries of what is possible. To achieve our ambition, we welcome talented individuals with diverse backgrounds and experiences - not just the brightest minds, but those who truly care about making a meaningful difference. With a team of approximately 7,500 employees and operations in more than 40 countries, we are a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology. We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need. UCB – The Facts • 7500 people in 40 countries, with over 70 nationalities • 49% women, 51% men • ~25% of revenue invested in R&D • Total revenue grew to €4.9 billion in 2019

The Hartford is a leader in property and casualty insurance, group benefits and mutual funds. We have a passion for helping people and businesses prepare for the unexpected, protect what is uniquely important to them, and prevail when the unforeseen happens – and we’ve been delivering on this for more than 200 years. We’ve helped people prevail after some of America’s largest disasters, including the San Francisco Earthquake of 1906, the September 11 terrorist attacks, and more recently, Hurricane Katrina and Sandy. We’ve also provided insurance for some of the largest construction projects ever such as Hoover Dam and the Golden Gate Bridge. Today, it includes everything from great new sports stadiums and arenas to universities, hospitals and museums.

Ranbaxy Laboratories is one of India's largest drug manufacturers and a top global generics producer. Anti-infectives amoxycillin (not to be confused with the common antibiotic, amoxicillin) and ciprofloxacin, and cardio drug simvastatin are among Ranbaxy's top sellers; all come in several administration forms. The company also makes treatments for gastrointestinal, musculoskeletal, and central nervous system disorders, as well as diabetes, pain, allergies, and HIV/AIDS. Its R&D focus includes new forms of existing drugs and metabolic disease treatments. Japanese drugmaker Daiichi Sankyo owns a controlling stake in Ranbaxy.